HIV drug development: the next 25 years | Nature Reviews Drug Discovery
Bioinformatics-assisted anti-HIV therapy | Nature Reviews Microbiology
HIV infection | Nature Reviews Disease Primers
Scientists identify second HIV patient whose body appears to have rid itself of the virus | Ragon Institute of Mass General, MIT, and Harvard
Alarming surge in drug-resistant HIV uncovered
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy | Nature
HIV infection | Nature Reviews Disease Primers
Risk and resiliency: the syndemic nature of HIV/AIDS in the indigenous highland communities of Ecuador - ScienceDirect
Dendritic-cell interactions with HIV: infection and viral dissemination | Nature Reviews Immunology
HIV infection | Nature Reviews Disease Primers
HIV enters deep sleep in people who naturally control the virus
Nuclear landscape of HIV-1 infection and integration | Nature Reviews Microbiology
Integrase inhibitors to treat HIV/Aids | Nature Reviews Drug Discovery
HIV research
Tied down by its own receptor | Nature
HIV Virion | Biophysical chemistry laboratory
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes | Nature Reviews Drug Discovery
The causes and consequences of HIV evolution | Nature Reviews Genetics
HIV infection | Nature Reviews Disease Primers
Immunology and the elusive AIDS vaccine | Nature
Wallchart Request Immune Response to HIV
HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers
Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? | Nature Reviews Microbiology
